Phone within the US
1-(800)-637-0839Outside the US only
1-(609)-298-1035Address
The MDS Foundation
4573 South Broad St., Suite 150
Yardville, NJ 08620
A global non-profit advocacy organization, supporting patients, families and healthcare providers in the fields of MDS and its related diseases for over 30 years
© 2024 MDS Foundation. All rights reserved.
March 13, 2021
Factors to Consider in the Initial Treatment Approach
This webinar will provide an overview of MDS and what treatment path to take in a patient newly diagnosed with myelodysplastic syndromes. Factors, such as: the type of MDS; the prognostic score (risk score) of the MDS; a person’s age, overall health, and preferences will be discussed.
Yazan F. Madanat, MD
Access to the meeting outputs are available below by clicking on each topic.
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, Acceleron, and Gamida Cell for supporting this initiative.